Actos Lawsuit

Actos Lawsuit
Thousands of Actos lawsuits have been filed on behalf of patients who allegedly developed bladder cancer due to extended use of the Type 2 diabetes medication. Takeda Pharmaceuticals has agreed to fund a $2.37 billion settlement to resolve the vast majority of those claims.

Actos Legal Reviews

The nationwide law firm of Bernstein Liebhard LLP offers free legal reviews to Actos patients who may have developed bladder cancer as a result of this medication. To learn more, please contact our office at (888) 994-5118.

Actos Litigation News

  • September 2015: The Actos bladder cancer settlement is finalized, after 96% of eligible claimants agree to the accord.
  • April 2015: Takeda agreed to fund a $2.37 billion Actos settlement to resolve the bladder cancer litigation. Read More
  • October 2014: The $9 billion judgment awarded in the first federal Actos trial is reduced to $36.8 million, “the maximum amount a jury could have properly awarded” under current U.S. law. Read More
  • April 2014: The jury hearing the first bellwether trial in the federal Actos litigation has found that Takeda and Eli Lilly & Co. concealed the risk of bladder cancer associated with the drug, and awarded the Plaintiff $1.5 million in compensatory damages. The panel also ordered the defendants to pay an additional $9 billion in punitive damages after finding that they “acted with wanton and reckless disregard” for patients’ safety. Read More
  • February 2014: The federal judge overseeing the Actos bladder cancer multidistrict litigation in the U.S. District Court, Western District of Louisiana, rules that jurors can be told that Takeda intentionally destroyed documents related to the development, marketing and sale of Actos. “The breadth of Takeda leadership whose files have been lost, deleted or destroyed is, in and of itself, disturbing,” the judge wrote in her January 27th order.Read More
  • September 2013: The nation’s second Actos trial ends with a Maryland jury finding for the family of a man who died as a result of bladder cancer the previous year. They are awarded $1.7 million. However, the presiding judge throws out the verdict in accordance with Maryland law because the jury also found that the decedent’s 30-year smoking habit contributed to the development of the disease. Read More
  • May 2013: The California Superior Court judge overseeing the nation’s first Actos bladder cancer trial grants Takeda’ motion to nullify the verdict, after finding that that the plaintiff’s medical expert had failed to establish that Actos was the specific cause of his cancer. Read More
  • April 2013: The first Actos trial involving bladder cancer allegations ends after a California Superior Court jury finds that Takeda failed to warn consumers that Actos could cause bladder cancer. The plaintiff and his wife are awarded $6.5 million in compensatory damages.
  • December 2011: Federally-filed Actos bladder cancer lawsuits are centralized in the U.S. District Court, Western District of Louisiana. Read More

How Can an Actos Lawsuit Help?

The Actos litigation began to grow in 2011, after the U.S. Food & Drug Administration announced in June that the “Warnings and Precautions” sections of the drug’s label would be modified to warn that use of the medication for a year or more had been linked to a 40% increased risk of bladder cancer. Actos lawsuit plaintiffs claim that Takeda was aware of this problem, but misled regulators and failed to warn consumers about the drug’s potential association with bladder cancer.

In December 2016, the FDA announced that a new review had failed to rule out an association between Actos and an increased risk of bladder cancer.  The agency indicated that it was updating the labels for Actos and related medications once again to describe the additional studies covered by this latest review. Read More

Taking legal action against Takeda may enable alleged victims of Actos bladder cancer, as well as their families, to obtain compensation for all of their injury-related damages, including:

  • Medical expenses
  • Lost earnings (past and future),
  • Pain and suffering
  • Loss of consortium
  • Wrongful death
  • Emotional distress
  • Punitive damages

If you would like to learn more about filing your own Actos lawsuit, please contact our Firm today by calling (888) 994-5118.

  1. FiercePharma (2015) “Takeda gets enough takers to complete $2.3B Actos settlement”
  2. Bloomberg (2014) “Takeda, Lilly Win 99.6% Cut in Actos Punitive Damages”
  3. FDA (2011) “FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer”


Last Modified: December 14, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content